Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 21, 2026 08:30 ET | Source: Nuwellis, Inc.

Nuwellis Announces Aquadex Software Update

MINNEAPOLIS, April 21, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on solutions for patients with cardiorenal conditions, today announced a software...
April 16, 2026 08:30 ET | Source: Nuwellis, Inc.

Nuwellis Welcomes Back Three Former Team Members to Accelerate Commercial and Clinical Momentum

MINNEAPOLIS, April 16, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces the...
April 09, 2026 08:30 ET | Source: Nuwellis, Inc.

Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services

MINNEAPOLIS, April 09, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces it...
April 07, 2026 08:30 ET | Source: Nuwellis, Inc.

Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory

MINNEAPOLIS, April 07, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today...
March 31, 2026 08:30 ET | Source: Nuwellis, Inc.

Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone

MINNEAPOLIS, March 31, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces...
March 17, 2026 08:00 ET | Source: Nuwellis, Inc.

Nuwellis Completes Acquisition of Rendiatech

MINNEAPOLIS, March 17, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today...
March 10, 2026 08:15 ET | Source: Nuwellis, Inc.

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

MINNEAPOLIS, March 10, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today reported...
March 05, 2026 08:00 ET | Source: Nuwellis, Inc.

Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

MINNEAPOLIS, March 05, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today...
February 26, 2026 08:00 ET | Source: Nuwellis, Inc.

Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors

MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced...
February 24, 2026 08:00 ET | Source: Nuwellis, Inc.

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

MINNEAPOLIS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced...